ACG clinical guideline: disorders of the hepatic and mesenteric circulation

DA Simonetto, AK Singal, G Garcia-Tsao… - Official journal of the …, 2020 - journals.lww.com
Disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries
have important clinical consequences and may lead to acute liver failure, chronic liver …

Vascular endothelial cell specification in health and disease

C Marziano, G Genet, KK Hirschi - Angiogenesis, 2021 - Springer
There are two vascular networks in mammals that coordinately function as the main supply
and drainage systems of the body. The blood vasculature carries oxygen, nutrients …

Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia

ME Faughnan, JJ Mager, SW Hetts… - Annals of internal …, 2020 - acpjournals.org
Description: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant
disease with an estimated prevalence of 1 in 5000 that is characterized by the presence of …

An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study

H Al-Samkari, RS Kasthuri, JG Parambil… - …, 2020 - pmc.ncbi.nlm.nih.gov
Hereditary hemorrhagic telangiectasia (HHT, Osler-Weber-Rendu disease) is a rare
multisystem vascular disorder that causes chronic gastrointestinal bleeding, epistaxis, and …

Future treatments for hereditary hemorrhagic telangiectasia

F Robert, A Desroches-Castan, S Bailly… - Orphanet journal of rare …, 2020 - Springer
Abstract Hereditary Hemorrhagic Telangiectasia (HHT), also known as Rendu-Osler
syndrome, is a genetic vascular disorder affecting 1 in 5000–8000 individuals worldwide …

Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care

H Al-Samkari - Blood, The Journal of the American Society of …, 2021 - ashpublications.org
Hereditary hemorrhagic telangiectasia (HHT) management is evolving because of the
emergence and development of antiangiogenic therapies to eliminate bleeding …

Vascular malformations syndromes: an update

A Martinez-Lopez, L Salvador-Rodriguez… - Current Opinion in …, 2019 - journals.lww.com
Some vascular malformations can be associated with other anomalies, such as tissue
overgrowth. PIK3CA-related overgrowth spectrum (PROS) is a group of rare genetic …

Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of NeuroInterventional Surgery Standards and …

R De Leacy, SA Ansari, CM Schirmer… - Journal of …, 2022 - jnis.bmj.com
Background The purpose of this review is to summarize the data available for the role of
angiography and embolization in the comprehensive multidisciplinary management of brain …

The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care

CL Shovlin, E Buscarini, C Sabbà, HJ Mager… - European Journal of …, 2022 - Elsevier
Hereditary haemorrhagic telangiectasia (HHT) is a complex, multisystemic vascular
dysplasia affecting approximately 85,000 European Citizens. In 2016, eight founding centres …

Potential second-hits in hereditary hemorrhagic telangiectasia

C Bernabeu, P Bayrak-Toydemir, J McDonald… - Journal of Clinical …, 2020 - mdpi.com
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant genetic disorder
that presents with telangiectases in skin and mucosae, and arteriovenous malformations …